Quoin Pharmaceuticals Ltd DRC
Price & Volume
Stats
See moreOpen | $5.89 |
Previous Close | $5.91 |
Day Range | $5.65-$5.89 |
52W Range | $5.20-$23.50 |
Market Cap | $11.1M |
Shares Short | 85,556 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$10.07 |
News
See moreYahoo Finance • 16 days ago
Quoin Pharma Plans To Initiate QRX009 Trial For Pachyonychia Congenita In Q3 2026; Stock Up
Yahoo Finance • 16 days ago
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
Yahoo Finance • 2 months ago
Quoin Updates On Type C Meet With FDA For QRX003 In NS; On Track To Initiate Phase 3 Trial In 2026
Yahoo Finance • 6 months ago
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
About
CEO | Dr. Michael Myers Ph.D. |
Address | 42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |